Real-world efficacy and safety of PD-1 inhibitors in patients living with HIV and cancer: a retrospective cohort study - Poll - MDSpire

Real-world efficacy and safety of PD-1 inhibitors in patients living with HIV and cancer: a retrospective cohort study

  • By

  • Xiaola Xue

  • Juyi Wu

  • Zhenpeng Tan

  • Chunyu Tian

  • Qiong Li

  • Shujuan Zhou

  • Yuchao Xia

  • Shaojie Yang

  • Xuan Yang

  • June 24, 2026

  • 0 min

Share

Original Source(s)

Real-world efficacy and safety of PD-1 inhibitors in patients living with HIV and cancer: a retrospective cohort study

  • by Xiaola Xue, Juyi Wu, Zhenpeng Tan, Chunyu Tian, Qiong Li, Shujuan Zhou, Yuchao Xia, Shaojie Yang, Xuan Yang

  • June 24, 2026

Related Content

Case Report: First report of PIK3CA-related overgrowth spectrum revealed by refractory chylorrhea after breast-conserving surgery: failed thoracic-duct ligation

Efficacy and safety of reduced-dose daratumumab plus bortezomib and dexamethasone (DVd-lite) in newly diagnosed MGRS patients

Hepatic safety of sintilimab versus pembrolizumab in advanced non-small cell lung cancer: a retrospective observational cohort study